Adamis Pharmaceuticals (NASDAQ: ADMP)
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.070 | -0.0400 | ||||
REV | 1.155M |
Q4 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.040 | -0.050 | -0.0100 | ||||
REV | 2.820M | 1.159M | -1.661M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Adamis Pharmaceuticals (NASDAQ: ADMP) through any online brokerage.
Other companies in Adamis Pharmaceuticals’s space includes: Opiant Pharma (NASDAQ:OPNT), Iterum Therapeutics (NASDAQ:ITRM), WAVE Life Sciences (NASDAQ:WVE), SCYNEXIS (NASDAQ:SCYX) and Lipocine (NASDAQ:LPCN).
The latest price target for Adamis Pharmaceuticals (NASDAQ: ADMP) was reported by Maxim Group on Wednesday, May 13, 2020. The analyst firm set a price target for 1.50 expecting ADMP to rise to within 12 months (a possible 238.68% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Adamis Pharmaceuticals (NASDAQ: ADMP) is $0.4429 last updated Today at May 19, 2022, 4:13 PM UTC.
There are no upcoming dividends for Adamis Pharmaceuticals.
Adamis Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 16, 2022.
There is no upcoming split for Adamis Pharmaceuticals.
Adamis Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.